Espinola N, Rodríguez Cairoli F, Rojas-Roque C, Luna PC, Kanevsky D, Migliazza V, et al. Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina. Expert Rev Pharmacoecon Outcomes Res. 2024;25(1):101-11.
